semaglutide effects on heart and cardiovascular outcomes in patients with obesity and prevalent failure: a prespecified analysis of the SELECT trial semaglutide effects on heart Cardiovascular

Patients experiencing cold sensitivity whilst on GLP-1 therapy can implement several practical strategies to maintain comfort without discontinuing beneficial treatment

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight

Rarely, patients may experience palpitations or perceive the increased heart rate, though these symptoms usually do not require treatment discontinuation

To limit these gastrointestinal side effects, your GP or private healthcare provider will likely start you on a low dose of semaglutide and gradually increase your dose over time

FAQs Why is GLP-1 considered a major target in translational metabolic research